ImmunityBio
Agent26Agent Readiness: 26/100. Bottom 25%. Measured by StartupHub.ai. Median 41.A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
About
ImmunityBio is a biotechnology company developing immunotherapies to treat cancer and infectious diseases by activating the patient's innate and adaptive immune systems. Their approach aims to deliver durable responses by stimulating various immune cells and building immunological memory. The company's investigational products, including ANKTIVA®, are designed to reprogram the immune system to conquer difficult diseases.
Key facts
At-a-glance profile data
- Website
- immunitybio.com
- Headquarters
- Culver City, California, USA
- Founded
- 2014
- Employees
- 620
- Total funding
- $75M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 31 Mar 2026 | Funding Round | $75M | - |
Tech stack
Detected on immunitybio.com, last scanned 24 Sept 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Tag Manager, Meta Pixel
- SEO
- Yoast SEO
- Support
- HubSpot
- CMS / Builders
- WordPress
- CDN
- Cloudflare
Frequently asked
How much funding has ImmunityBio raised?
ImmunityBio has raised a total of $75M in funding. The most recent round on record is Funding Round.
How many employees does ImmunityBio have?
ImmunityBio has approximately 620 people on record.